Our cell culture media production in Tilburg are "animal component free", i.e. without animal or human ingredients and is used by Fujifilm Irvine Scientific's customers for growing cells on Petri dishes or in bioreactors. The new plant produces cell culture media powder mixtures, cell culture media solutions and Water For Injection (WFI).
The new Life Science Manufacturing facility fits within Fujifilm's Sustainability Value Plan 2030 for sustainable growth. Fujifilm's strategy focuses on climate change, energy issues and promoting resource reuse. For our new facility, this means specifically:
Corporate Vice President, GM, Life Sciences Business Div
FUJIFILM is continuously expanding its activities in the field of preventive healthcare and treatment. At the end of 2021, FUJIFILM opened a new Life Science Manufacturing factory in Tilburg. In this factory, cell culture media is being produced. Cell culture media are used in the biopharmaceutical industry and serve as nutrients for cells when making drugs or vaccines (e.g. COVID). This biopharmaceutical market is growing at high speed. European Life Science Manufacturing Facility (2021)
In addition to the FUJIFILM Irvine Scientific production facilities for cell culture media in the United States and Japan, there was a need to expand with a third production facility in Europe. On the premises of FUJIFILM Manufacturing Europe B.V. in Tilburg, this Life Science Manufacturing plant has been built in the former photo film factory. The clean room production in Tilburg takes place under strict quality requirements.
The production of cell culture media is a complex technological process. FUJIFILM in Tilburg has this production expertise, facilities and excellent logistical infrastructure to serve the European market. We are also prepared for the growing market demand with room for future expansion in our Life Science Manufacturing environment.